PT-141 (Bremelanotide)
Melanocortin receptor agonist — also known as Vyleesi®
The only FDA-approved peptide specifically for hypoactive sexual desire disorder (HSDD) in premenopausal women. Works centrally via the brain's melanocortin system — not through hormones. Also used off-label in men for libido and erectile function.